My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 165

    1.

    Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects.

    Henry RR, Mudaliar SR, Howland WC 3rd, Chu N, Kim D, An B, Reinhardt RR.

    Diabetes Care. 2003 Mar;26(3):764-9.PMID: 12610035 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparison.

    Henry RR, Mudaliar S, Chu N, Kim D, Armstrong D, Davis TT, An B, Reinhardt RR.

    J Clin Pharmacol. 2003 Nov;43(11):1228-34.PMID: 14551177 [PubMed - indexed for MEDLINE]Related articles

    3.

    Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System.

    McElduff A, Mather LE, Kam PC, Clauson P.

    Br J Clin Pharmacol. 2005 May;59(5):546-51. Erratum in: Br J Clin Pharmacol. 2005 Jul;60(1):114. PMID: 15842553 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The impact of smoking on inhaled insulin.

    Himmelmann A, Jendle J, Mellén A, Petersen AH, Dahl UL, Wollmer P.

    Diabetes Care. 2003 Mar;26(3):677-82.PMID: 12610021 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes.

    Hermansen K, Rönnemaa T, Petersen AH, Bellaire S, Adamson U.

    Diabetes Care. 2004 Jan;27(1):162-7.PMID: 14693983 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pulmonary insulin administration using the AERx system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects.

    Farr SJ, McElduff A, Mather LE, Okikawa J, Ward ME, Gonda I, Licko V, Rubsamen RM.

    Diabetes Technol Ther. 2000 Summer;2(2):185-97.PMID: 11469258 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of different durations of breath holding after inhalation of insulin using the AERx insulin diabetes management system.

    An B, Reinhardt RR.

    Clin Ther. 2003 Aug;25(8):2233-44.PMID: 14512131 [PubMed - indexed for MEDLINE]Related articles

    8.

    AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthma.

    Wolzt M, de la Peña A, Berclaz PY, Tibaldi FS, Gates JR, Muchmore DB.

    Diabetes Care. 2008 Apr;31(4):735-40. Epub 2008 Jan 11.PMID: 18192544 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin.

    Kapitza C, Hompesch M, Scharling B, Heise T.

    Diabetes Technol Ther. 2004 Aug;6(4):466-72.PMID: 15321001 [PubMed - indexed for MEDLINE]Related articles

    10.

    Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.

    Brunner GA, Balent B, Ellmerer M, Schaupp L, Siebenhofer A, Jendle JH, Okikawa J, Pieber TR.

    Diabetologia. 2001 Mar;44(3):305-8.PMID: 11317660 [PubMed - indexed for MEDLINE]Related articles

    11.

    AIR inhaled insulin in subjects with chronic obstructive pulmonary disease: pharmacokinetics, glucodynamics, safety, and tolerability.

    Rave K, de la Peña A, Tibaldi FS, Zhang L, Silverman B, Hausmann M, Heinemann L, Muchmore DB.

    Diabetes Care. 2007 Jul;30(7):1777-82. Epub 2007 Apr 24.PMID: 17456839 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The effect of exercise on the absorption of inhaled human insulin via the AERx insulin diabetes management system in people with type 1 diabetes.

    Petersen AH, Köhler G, Korsatko S, Wutte A, Wonisch M, Jeppesen OK, Sparre T, Clauson P, Laursen T, Wollmer P, Pieber TR.

    Diabetes Care. 2007 Oct;30(10):2571-6. Epub 2007 Jul 9.PMID: 17620446 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin.

    Becker RH, Sha S, Frick AD, Fountaine RJ.

    Diabetes Care. 2006 Feb;29(2):277-82.PMID: 16443873 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS).

    Mudaliar S.

    Expert Opin Investig Drugs. 2007 Oct;16(10):1673-81. Review.PMID: 17922630 [PubMed - indexed for MEDLINE]Related articles

    15.

    Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System.

    Cramer JA, Okikawa J, Bellaire S, Clauson P.

    Diabetes Technol Ther. 2004 Dec;6(6):800-7.PMID: 15684632 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin inhalation: NN 1998.

    [No authors listed]

    Drugs R D. 2004;5(1):46-9. Review.PMID: 14725493 [PubMed - indexed for MEDLINE]Related articles

    17.

    Delivering needle-free insulin using AERx iDMS (insulin diabetes management system) technology.

    Wollmer P, Pieber TR, Gall MA, Brunton S.

    Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S57-64.PMID: 17563305 [PubMed - indexed for MEDLINE]Related articles

    18.

    Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.

    Moses RG, Bartley P, Lunt H, O'Brien RC, Donnelly T, Gall MA, Vesterager A, Wollmer P, Roberts A.

    Diabet Med. 2009 Mar;26(3):260-7.PMID: 19317821 [PubMed - indexed for MEDLINE]Related articles

    19.

    Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.

    Kim D, Mudaliar S, Chinnapongse S, Chu N, Boies SM, Davis T, Perera AD, Fishman RS, Shapiro DA, Henry R.

    Diabetes Care. 2003 Oct;26(10):2842-7.PMID: 14514589 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.

    Rave KM, Nosek L, de la Peña A, Seger M, Ernest CS 2nd, Heinemann L, Batycky RP, Muchmore DB.

    Diabetes Care. 2005 Oct;28(10):2400-5.PMID: 16186270 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity